|
MTFR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.488800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.960990E-01 |
| Normal-vs-Stage2 |
7.463200E-01 |
| Normal-vs-Stage3 |
3.289000E-01 |
| Normal-vs-Stage4 |
2.424000E-01 |
| Stage1-vs-Stage2 |
6.001400E-01 |
| Stage1-vs-Stage3 |
9.916600E-01 |
| Stage1-vs-Stage4 |
7.972000E-01 |
| Stage2-vs-Stage3 |
6.248400E-01 |
| Stage2-vs-Stage4 |
5.054600E-01 |
| Stage3-vs-Stage4 |
7.671200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.741800E-01 |
| Normal-vs-AfricanAmerican |
2.476400E-02 |
| Normal-vs-Asian |
2.737600E-01 |
| Caucasian-vs-AfricanAmerican |
9.610000E-02 |
| Caucasian-vs-Asian |
6.048400E-01 |
| AfricanAmerican-vs-Asian |
9.267800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.500000E-01 |
| Normal-vs-Female |
2.318800E-01 |
| Male-vs-Female |
9.525800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.887900E-02 |
| Normal-vs-Extreme_Weight |
3.080400E-02 |
| Normal-vs-Obese |
8.043400E-01 |
| Normal-vs-Extreme_Obese |
8.094400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.243000E-01 |
| Normal_Weight-vs-Obese |
6.087700E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.544800E-01 |
| Extreme_Weight-vs-Obese |
7.156300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.831200E-01 |
| Obese-vs-Extreme_Obese |
9.543000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.536200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.807800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.553580E-01 |
| Normal-vs-Age(81-100Yrs) |
4.538800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.540000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.888600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.708400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.018000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.809000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.641000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.963760E-01 |
| Normal-VS-Type2 PRCC |
8.552600E-01 |
| Normal-VS-KIRP CIMP |
6.069700E-02 |
| Normal-VS-Unclassified PRCC |
3.220200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.202000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.200600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.577000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.952560E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.267200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.648800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.890200E-01 |
| Normal-vs-N1 |
3.781800E-01 |
| Normal-vs-N2 |
7.570800E-01 |
| N0-vs-N1 |
9.083800E-01 |
| N0-vs-N2 |
8.721800E-01 |
| N1-vs-N2 |
8.927600E-01 |
|
|
